O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance

Clin Infect Dis. 2022 Jan 29;74(2):364-366. doi: 10.1093/cid/ciab458.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial
  • Escherichia coli
  • Escherichia coli Infections* / epidemiology
  • Escherichia coli Infections* / prevention & control
  • Humans
  • Morbidity
  • O Antigens / immunology
  • Vaccines*

Substances

  • Anti-Bacterial Agents
  • O Antigens
  • Vaccines